Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03585465
Title Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Centre Oscar Lambret


low grade glioma

Ewing sarcoma


central nervous system embryonal carcinoma

high grade ependymoma


Capecitabine + Cyclophosphamide + Nivolumab + Vinblastine

Capecitabine + Cyclophosphamide + Vinblastine

Cyclophosphamide + Nivolumab + Vinblastine

Capecitabine + Nivolumab

Age Groups: adult | child
Covered Countries FRA | BEL

No variant requirements are available.